LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EQUITY FLASH M impact Oct 05, 2026, 10:59 AM UTC

Viatris to report third-quarter 2026 financial results on November 5, 2026

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

VTRS

Related stories

Tesla Stock Faces Scrutiny Ahead of Q3 Earnings Amid Strong Deliveries Following a strong Q3 delivery report that exceeded Wall Street expectations, investor focus now shifts to Tesla's upcoming earnings announcement on October 21. The company reporte M impact | EQUITY | Oct 05, 2026, 12:10 PM UTC DoorDash, Deliveroo and Coco Robotics launch U.K. sidewalk deliveries The companies will start autonomous sidewalk deliveries in Canary Wharf this October, then expand to Milton Keynes, Leeds, Stockton-on-Tees and Nottingham. L impact | EQUITY | Oct 05, 2026, 12:09 PM UTC Syntec Optics Lands Artemis III Production Orders for Moon Missions Syntec Optics Holdings, Inc. (NASDAQ:OPTX) announced recurring production orders for actuators to be used in NASA's Artemis III rocket, expanding its space portfolio to lunar missi M impact | EQUITY | Oct 05, 2026, 12:09 PM UTC Kratos wins more than $100 million in prototype contracts Kratos said it secured more than $100 million in contracts to develop prototype space-intelligence and cyber capabilities for U.S. joint operations. M impact | EQUITY | Oct 05, 2026, 12:09 PM UTC Revolution Medicines Starts Phase 3 Trial for Pancreatic Cancer Drug Revolution Medicines has begun treating patients in its Phase 3 RASolute 309 trial for its drug daraxonrasib (RASONQUE™) combined with zoldonrasib. The trial is evaluating the comb M impact | EQUITY | Oct 05, 2026, 12:09 PM UTC Big cap premarket movers on Brazil, PCVX, PTC Brazil names traded higher after Bolsonaro beat expectations in the presidential vote. PCVX rose on positive topline data from OPUS-1, while PTC gained after news it will be acquir M impact | EQUITY | Oct 05, 2026, 12:09 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.